CClinicalTrials.gg
CompletedNCT02888028Updated Jun 21, 2018

Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU

An interventional study of ICD remote monitoring and Control group in Anxiety and Depression, sponsored by LMU Klinikum. Completed at 2 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-06-21.

Sponsored by LMU Klinikum · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
182
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study investigates whether an additional remote follow-up of patients with implantable cardioverter-defibrillators (ICDs) has beneficial effects on Quality of life (QoL), levels of anxiety and depression and device acceptance. Patients are randomized to either conventional in-office FU only or additional remote surveillance, follow-up duration is 12 months. The influence of other variables (age, sex,..) is evaluated regarding their influence on study endpoints.

Read the detailed description

The rising number of implantable cardiac devices leads to an increasing amount of device-related workload, e.g. regular in-office follow-ups (FU). New means of ICD FU strategies are necessary to handle the increasing burden. ICD remote monitoring promises a time- and cost efficient alternative to conventional in-office FU strategies. Many studies have already shown benefits on FU burden reduction, on saving of costs and time, and recently on total mortality. The impact of remote ICD FU on Quality of life, anxiety and depression levels and device acceptance is still under discussion. The aim of this trial is to investigate the influence of additional remote ICD surveillance on the primary endpoint health related quality of life (HRQoL), further on levels of anxiety and depression and on device acceptance.

02

Conditions studied

  • Anxiety
  • Depression

Browse trials for

Keywords

  • Remote ICD follow-up
  • HRQoL
  • Health related Quality of Life
  • Depression
  • anxiety
  • device acceptance
  • telemedicine
  • telemonitoring
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 182 is above the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

LMU Klinikum is the lead sponsor of 51 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients willing to participate
  • Patients with new-implantation of an ICD or device replacement due to battery depletion between May 2011 and April 2013
  • Sufficient knowledge of the German language
  • Expectancy of life >1 years at good clinical status
  • Written informed consent

Exclusion criteria

Exclusion Criteria:

  • Age \<18 years
  • Subjects not able to give written informed consent
  • Subjects without sufficient German language skills
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
182 participants (actual)

Study arms

  • Active comparator
    ICD remote monitoring

    Active Comparator: ICD remote monitoring additionally to regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement

    Procedure: ICD remote monitoring

  • Other
    Control group

    Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU

    Other: Control group

Interventions

  • ProcedureICD remote monitoring

    ICD remote monitoring additionally to regular in-office visits

  • OtherControl group

    Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU

06

What researchers measure

Primary outcomes

  1. Influence of ICD remote monitoring on Quality of Life, measured by the EQ5D questionnaire

    Time frame: 12 months

Secondary outcomes

  1. Influence of ICD remote monitoring on levels of anxiety and depression, measured by the HADS questionnaire (Hospital Anxiety and Depression scale)

    Time frame: 12 months

  2. Influence of ICD remote monitoring on device acceptance, measured by the Florida Patient acceptance scale (FPAS)

    Time frame: 12 months

07

Study locations

2 sites
  • Bielefeld University, School of public health
    Bielefeld, 33615, Germany
  • Munich University Clinic, Campus Grosshadern
    Munich, 81377, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02888028
Lead sponsor
LMU Klinikum
Collaborators
Klinikum Bielefeld
Responsible party
Johannes Siebermair, MD (Johannes Siebermair, MD, LMU Klinikum) — Principal investigator
First posted
Sep 2, 2016
Start date
May 2011
Primary completion
Apr 2014
Completion
Jun 2014
Last update
Jun 21, 2018

Study contacts

Johannes Siebermair, MD
principal investigator · Munich University Clinic, Campus Grosshadern, Munich, Germany
Florian Leppert, MSc
principal investigator · Bielefeld University, School of public health Bielefeld, Germany
Stefan Kääb, MD
principal investigator · Munich University Clinic, Campus Grosshadern, Munich, Germany
Wolfgang Greiner, MD
principal investigator · Bielefeld University, School of public health, Bielefeld, Germany

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion